Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-854

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 01

Chemical structure of the active ingredients Levonorgestrel and Ethinyl Estradiol. The image shows molecular formulas, molecular weights, and structural diagrams for both compounds, highlighting key chemical groups.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 02

Two pharmacokinetic concentration-time graphs showing Levoronorgestrel and Ethinyl Estradiol levels in ng/mL and pg/mL, respectively, over 72 hours on Days 1, 6, and 21. Both charts illustrate a decline in concentration over time with markers for each day.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 03

A bar chart comparing four groups based on smoking status and control status (ever-users nonsmokers, ever-users smokers, controls nonsmokers, and controls smokers) across different age categories (15-24, 25-34, 35-44, 46+). The y-axis indicates values from 0 to 200. The highest values are observed in the ever-users smokers group, especially in the 46+ age category.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 04

A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (odds ratios or relative risks) from multiple studies. Each study is listed on the left with corresponding effect estimates and confidence intervals plotted as points and horizontal lines on the graph, which ranges from -1.5 to 2 on the x-axis representing effect estimates. The studies include both ever use and current use categories, with estimates mostly ranging around 1 or slightly above, indicating relative risk values with confidence intervals.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 05

A circular pill calendar diagram for a 28-day oral contraceptive pack organized by weeks (Week 1 to Week 4) and days (Sunday to Saturday). Arrows guide the user to follow the pill sequence, starting at Sunday in Week 1, with an instruction to perform a monthly self-breast exam noted on the right side of the layout.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 06

An instructional diagram depicting the weekly pill-taking schedule for a 28-day contraceptive pack labeled with days Sunday through Saturday arranged in four rows for Week 1 to Week 4. Arrows indicate the order of pill ingestion, starting on Sunday, with a reminder for a monthly self breast exam noted along the right side of the diagram. This is associated with Levonorgestrel and Ethinyl Estradiol oral contraceptive use.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 07

Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg packaging label showing a rectangular blister pack with four weeks of circular tablet slots labeled by day (Sunday to Saturday) and week (Week 1 to Week 4). The label includes storage instructions and manufacturer information for Lupin Pharmaceuticals, Inc., including a barcode and note for monthly self breast exam.*

FDA Label Image

Bd189086 341a 4c4d A8f4 9aa54ad7003b 08

Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg, by Lupin Pharmaceuticals, Inc. The label states Rx only and indicates the package contains 3 blisters of 28 tablets each. The label includes the NDC 68180-854-73 and distribution and manufacturing details, including Lupin Pharmaceuticals, Inc. in Baltimore, MD, and Lupin Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.